B
Bionoid Pharma Inc
OTC:BINP
Bionoid Pharma Inc
OTC:BINP
Price:
0.0999
USD
66.5%
Market Closed
Market Cap:
$5.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bionoid Pharma Inc
OTC:BINP
|
US |
|
Warehouses de Pauw NV
XBRU:WDP
|
BE |
|
E
|
Engenco Ltd
XBER:CDF
|
AU |
|
Nemak SAB de CV
BMV:NEMAKA
|
MX |
|
Allcargo Gati Ltd
NSE:ACLGATI
|
IN |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
D
|
Deliveroo PLC
OTC:DROOF
|
UK |
|
G
|
Golfzon Co Ltd
KOSDAQ:215000
|
KR |
|
Sogeclair SA
PAR:SOG
|
FR |
|
M
|
MMC Sanayi ve Ticari Yatirimlar AS
IST:MMCAS.E
|
TR |
|
D
|
Dalrymple Bay Infrastructure Ltd
ASX:DBI
|
AU |
|
I
|
International Consolidated Airlines Group SA
MAD:IAG
|
UK |
|
A Metaverse Co
HKEX:1616
|
CN |
|
Magnolia Oil & Gas Corp
NYSE:MGY
|
US |
|
Supercom Ltd
NASDAQ:SPCB
|
IL |
Balance Sheet
Balance Sheet Decomposition
Bionoid Pharma Inc
Bionoid Pharma Inc
Balance Sheet Decomposition is not available for
Bionoid Pharma Inc
Bionoid Pharma Inc
Balance Sheet
Bionoid Pharma Inc
Bionoid Pharma Inc
Currency: USD
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-4%
|
0
-9%
|
0
+18%
|
1
+183%
|
0
-77%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
2
|
1
|
|
| Short-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
2
|
2
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+123%
|
2
+41%
|
2
-2%
|
2
+16%
|
1
-43%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
6
|
7
|
11
|
15
|
20
|
|
| Additional Paid In Capital |
4
|
5
|
6
|
10
|
14
|
19
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
-507%
|
2
-67%
|
1
+7%
|
1
+39%
|
1
-9%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-4%
|
0
-9%
|
0
+18%
|
1
+183%
|
0
-77%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
